FernandoCTrespalaciosMD

PubMed

• 70 citations
  Assessment of the duration of protection in Campylobacter jejuni experimental infection in humans.
  David R. Tribble, Shahida Baqar, Daniel A. Scott, Michael L. Oplinger, Fernando Trespalacios, David M. Rollins, Richard I. Walker, John D. Clements, Steven S. Walz, Pa...> ;Infection and Immunity. 2010 Apr 1
• 33 citations
  Immune Response, Ciprofloxacin Activity, and Gender Differences after Human Experimental Challenge by Two Strains of Enterotoxigenic Escherichia coli
  Trinka S. Coster, Marcia K. Wolf, Eric R. Hall, Frederick J. Cassels, David N. Taylor, C. T. Liu, F. C. Trespalacios, Alfred A. deLorimier, D. R. Angleberger, Charles ...> ;Infection and Immunity. 2007 Jan 1
• 99 citations
  β-Blocker Use in Long-term Dialysis Patients: Association With Hospitalized Heart Failure and Mortality
  Kevin C. Abbott, Fernando C Trespalacios, Lawrence Y. Agodoa, Allen J. Taylor, George L. Bakris> ;Archives of Internal Medicine. 2004 Dec 13
• 207 citations
  Body mass index, dialysis modality, and survival: Analysis of the United States Renal Data System Dialysis Morbidity and Mortality Wave II Study
  Kevin C. Abbott, Christopher W. Glanton, Fernando C Trespalacios, David K. Oliver, Maria I. Ortiz, Lawrence Y. Agodoa, David F. Cruess, Paul L. Kimmel> ;Kidney International. 2004 Feb 1
• 64 citations
  Two studies evaluating the safety and immunogenicity of a live, attenuated Shigella flexneri 2a vaccine (SC602) and excretion of vaccine organisms in North American vo...
  David E. Katz, Trinka S. Coster, Marcia K. Wolf, Fernando C. Trespalacios, Dani Cohen, Guy Robins, Antoinette B. Hartman, Malabi M. Venkatesan, David N. Taylor, Thomas...> ;Infection and Immunity. 2004 Feb 1
• 13 citations
  Arteriovenous fistula use and heart disease in long-term elderly hemodialysis patients: analysis of United States Renal Data System Dialysis Morbidity and Mortality Wa...
  Kevin C. Abbott, Fernando C Trespalacios, Lawrence Y. Agodoa> ;Journal of Nephrology. 2003 Nov 1
• 31 citations
  HIVAN and medication use in chronic dialysis patients in the United States: analysis of the USRDS DMMS Wave 2 study
  Kevin C. Abbott, Fernando C Trespalacios, Lawrence Y. Agodoa, Tejinder S. Ahuja> ;BMC Nephrology. 2003 Jul 1
• 111 citations
  Heart failure as a cause for hospitalization in chronic dialysis patients.
  Fernando C Trespalacios, Allen J. Taylor, Lawrence Y. Agodoa, George L. Bakris, Kevin C. Abbott> ;American Journal of Kidney Diseases. 2003 Jun 1
• 23 citations
  Survival by time of day of hemodialysis: analysis of United States renal data system dialysis morbidity and mortality waves III/IV
  Kevin C. Abbott, Joel C. Reynolds, Fernando C Trespalacios, David F. Cruess, Lawrence Y. Agodoa> ;American Journal of Kidney Diseases. 2003 Apr 1
• 129 citations
  Atrial fibrillation in chronic dialysis patients in the United states: risk factors for hospitalization and mortality
  Kevin C. Abbott, Fernando C Trespalacios, Allen J. Taylor, Lawrence Y. Agodoa> ;BMC Nephrology. 2003 Jan 24
• 88 citations
  Incident acute coronary syndromes in chronic dialysis patients in the United States
  Fernando C. Trespalacios, Allen J. Taylor, Lawrence Y. Agodoa, Kevin C. Abbott> ;Kidney International. 2002 Nov 1
• 76 citations
  Safety, tolerability, and lack of antibody responses after administration of a PfCSP DNA malaria vaccine via needle or needle-free jet injection, and comparison of int...
  Judith E. Epstein, Edward J. Gorak, Yupin Charoenvit, Ruobing Wang, Nicole Freydberg, Oluwatoyin Osinowo, Thomas L. Richie, Erin L. Stoltz, Fernando Trespalacios, John...> ;Human Gene Therapy. 2002 Sep 1
• 12 citations
  Scleroderma at end stage renal disease in the United States: patient characteristics and survival.
  Kevin C. Abbott, Fernando C Trespalacios, Paul G. Welch, Lawrence Y. Agodoa> ;Journal of Nephrology. 2002 May 1
• Join now to see all